VACCINEX, INC. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vaccinex, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • Vaccinex, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $112K, a 11.1% decline year-over-year.
  • Vaccinex, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $427K, a 18% decline year-over-year.
  • Vaccinex, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $474K, a 13% decline from 2022.
  • Vaccinex, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $545K, a 0.74% increase from 2021.
  • Vaccinex, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $541K, a 26.1% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $474K -$71K -13% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-04-25
2022 $545K +$4K +0.74% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-04-25
2021 $541K -$191K -26.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $732K +$285K +63.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $447K +$270K +153% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $177K -$142K -44.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 $319K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.